Cameco (TSX:CCO) Has Investors Asking A Bigger Question
Cameco (TSX:CCO) is back in focus after its 31 July 2026 earnings release, which showed sharply lower second quarter net income and earnings per share compared with the same period a year earlier.
See our latest analysis for Cameco.
Cameco’s recent second quarter earnings update and 2026 revenue guidance landed against a mixed price backdrop, with the share price at CA$135.66 and short term momentum soft compared with a strong multi year total shareholder return of 563.46% over five years.
If you are interested in how other nuclear related stocks have been trading after recent earnings updates, it could be worth scanning the 89 nuclear energy infrastructure stocks
Cameco’s share price has cooled after a strong multi year run, even as earnings have softened and new 2026 revenue guidance is on the table. Does that backdrop favour buying now, or waiting for a cleaner entry point?
Most Popular Narrative: 23.9% Undervalued
Cameco’s most followed valuation narrative puts fair value at CA$178.28, above the recent CA$135.66 share price, and ties that gap to long run uranium demand and contracting trends.
Cameco stands to benefit from a global wave of new nuclear construction, driven by heightened government policy support, net-zero emission mandates, and growing energy security concerns. These factors are likely to accelerate demand for uranium and nuclear fuel, directly supporting higher long-term revenues.
Momentum in utility contracting is building, but current volumes are subdued. As uncovered utility uranium needs through 2045 accumulate, the eventual surge in term contracting is expected to drive material price and volume upside, improving both Cameco's revenue growth and pricing power, with likely gains to net margins.
Want to see what is baked into that fair value gap for Cameco? The narrative leans on a specific mix of revenue growth, margin expansion and richer long term earnings multiples that many investors would usually associate with faster growing sectors.
Result: Fair Value of CA$178.28 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you also need to weigh the risk that new reactor projects are delayed and that long term uranium contracting remains slower than analysts currently assume.
Find out about the key risks to this Cameco narrative.
Another View: What Cameco’s Sales Multiple Is Telling You
The 23.9% undervalued narrative for Cameco sits awkwardly next to the current P/S of 17x. That compares with 11.5x for peers and a fair ratio of 2.3x that the market could move towards, which implies meaningful valuation risk if expectations are not met.
For investors, that gap raises a simple question: Is Cameco priced for a future that is already quite optimistic, or is the market underestimating how long premium uranium and fuel margins can last?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mix of optimism and concern around Cameco, it makes sense to look through the numbers and sentiment for yourself and decide how comfortable you are with that balance of risks and rewards. A good next step is to review the 2 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Cameco?
If Cameco has your attention, do not stop here. Use the Simply Wall Street Screener to identify other opportunities that fit your style before the crowd does.
- Target potential mispricings by reviewing companies that screen as high quality yet are still priced at a discount through the 13 high quality undervalued stocks.
- Prioritise resilience by checking stocks that show strong financial footing and prudent leverage using the solid balance sheet and fundamentals stocks screener (12 results).
- Hunt for future standouts by scanning a screener containing 8 high quality undiscovered gems before they attract wider attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com